Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
synthetic drug
|
| gptkbp:alsoKnownAs |
gptkb:Stenabolic
|
| gptkbp:CASNumber |
1379686-30-2
|
| gptkbp:category |
research chemical
REV-ERB agonist |
| gptkbp:chemicalFormula |
available in public chemical databases
|
| gptkbp:compatibleWith |
gptkb:FDA
anabolic steroid |
| gptkbp:developedBy |
gptkb:The_Scripps_Research_Institute
|
| gptkbp:effect |
increases exercise capacity in mice
reduces fat mass in animal studies |
| gptkbp:firstDescribed |
2012
|
| gptkbp:hasMolecularFormula |
C20H24ClN3O4S
|
| https://www.w3.org/2000/01/rdf-schema#label |
SR 90000
|
| gptkbp:legalStatus |
not approved for human use
|
| gptkbp:mechanismOfAction |
increases mitochondrial activity
modulates circadian rhythm |
| gptkbp:molecularWeight |
437.94 g/mol
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:studiedBy |
obesity
metabolic disorders endurance enhancement |
| gptkbp:target |
gptkb:REV-ERBα
gptkb:REV-ERBβ |
| gptkbp:usedIn |
preclinical research
|
| gptkbp:bfsParent |
gptkb:SR_90000_(Virginia)
|
| gptkbp:bfsLayer |
7
|